Alto Neuroscience, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001999480-26-000012
- Form type
- 10-Q
- CIK
- 0001999480
- Primary document
- https://www.sec.gov/Archives/edgar/data/1999480/000199948026000012/alto-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Alto Neuroscience, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-27.1M | - | - |
| Net Income | $-26.2M | - | - |
| Eps Basic | -0.8 | - | - |
| Eps Diluted | -0.8 | - | - |
| Cash And Equivalents | $263.8M | - | - |
| Total Assets | $276.3M | - | - |
| Total Liabilities | $32.9M | - | - |
| Shareholders Equity | $243.4M | - | - |
| Operating Cash Flow | $-27.1M | - | - |
| Capital Expenditures | $556,000 | - | - |